AVDL - Avadel Pharmaceuticals plc (AVDL) CEO Greg Divis on Q1 2021 Results - Earnings Call Transcript
Avadel Pharmaceuticals plc (AVDL) Q1 2021 Earnings Conference Call May 10, 2021 8:30 A.M. ET Company Participants Tom McHugh - Chief Financial Officer Greg Divis - Chief Executive Officer Jennifer Gudeman - Vice President of Medical and Clinical Affairs Richard Kim - Chief Commercial Officer Conference Call Participants Paul Matteis - Stifel David Amsellem - Piper Sandler Francois Brisebois - Oppenheimer Madhu Yennawar - SVB Leerink David Sherman - Lifesci Capital Robin Garner - Craig-Hallum Oren Livnat - HC Wainwright Presentation Operator Greetings and welcome to the Avadel Pharmaceuticals First Quarter 2021 Earnings Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow the formal presentation. [Operator Instructions] As a reminder, this conference is being recorded. It is now my pleasure to introduce Tom McHugh, Chief Financial Officer. Thank you. You may begin. Tom McHugh Good morning and thank you for joining us on
For further details see:
Avadel Pharmaceuticals plc (AVDL) CEO Greg Divis on Q1 2021 Results - Earnings Call Transcript